We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Europe's Contrast Media Market to Reach $915 Million in 2008

By HospiMedica staff writers
Posted on 23 Oct 2002
Print article
Mediocre performance, sluggish growth, and a maturing market have affected Europe's contrast media industry, estimated at US$684 million in 2001, according to a new study by Frost & Sullivan (London, UK), the international marketing consulting company.

However, medical institutions are increasing imaging equipment installations that will continue to require the use of contrast media for imaging. Moreover, the growing number of these installations will increase patient throughput and the number of procedures performed. These factors will help push sales in the overall European contrast media market to $915 million in 2008, say Frost & Sullivan analysts. The star performer in the contrast media arena is magnetic resonance imaging (MRI), whose rising popularity as a reliable imaging tool is stimulating innovation and will prompt the launch of new MRI contrast agents.

Aiding this development is the defection from conventional x-ray modality, which will also have a favorable effect on computed tomography (CT) contrast media. However, MRI and ultrasound will be encroaching on the use of CT/x-ray, reducing their sector's share to 60.7% of the market in 2008. The price-sensitive nature of the market, caused by price erosion and saturation of the x-ray segment, is curtailing growth.

The contrast media industry's fortunes are linked to the performance of the medical imaging equipment market. "The penetration of medical imaging equipment will fuel demand for contrasting agents. Since many parts of Europe remain untapped by the imaging equipment industry, there are significant opportunities for increasing the installed base,” noted Sumit Sharma, research analyst at Frost & Sullivan.

CT has experienced the highest volume of procedures using contrast agents. Almost 12.2 million CT procedures were performed in Europe in 2001. Contributing to market saturation is the fact that some new imaging technologies completely minimize the use of contrast agents. Frost & Sullivan believes there will be a closer working environment between the contrast media industry and the imaging equipment industry in order to develop new contrast agents complementary to new technology-driven imaging equipment.




Related Links:
Frost & Sullivan
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Monitor Cart
Tryten S5
New
Mobile Power Procedure Chair
LeMans P360

Print article

Channels

Critical Care

view channel
Image: The BrioVAD System featuring the innovative BrioVAD Pump (Photo courtesy of BrioHealth Solutions)

Innovative Ventricular Assist Device Provides Long-Term Support for Advanced Heart Failure Patients

Advanced heart failure represents the final stages of heart failure, where the heart’s ability to pump blood effectively is severely compromised. This condition often results from underlying health issues... Read more

Surgical Techniques

view channel
Image: The new treatment combination for subdural hematoma reduces the risk of recurrence (Photo courtesy of Neurosurgery 85(6):801-807, December 2019)

Novel Combination of Surgery and Embolization for Subdural Hematoma Reduces Risk of Recurrence

Subdural hematomas, which occur when bleeding happens between the brain and its protective membrane due to trauma, are common in older adults. By 2030, chronic subdural hematomas are expected to become... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.